Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.
Sinogen Biopharma's investors include Qiming Venture Partners, Westlake Village BioPartners, CHERAMI, Puxin Capital, Winzac Capital.
Sinogen Biopharma is headquartered in Boston, United States.
Sinogen Biopharma is a developer of innovative drugs with a vision to bridge China's biotech innovation to the US pharma market.
Sinogen Biopharma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sinogen Biopharma — Funding & Investors." VCBacked, December 30, 2023, https://www.vcbacked.co/company/sinogen-biopharma. Accessed October 1, 2026.
VCBacked. (2023). Sinogen Biopharma — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/sinogen-biopharma
{{cite web |title=Sinogen Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/sinogen-biopharma |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated